Published on 5 Oct 2022 on Zacks via Yahoo Finance
Alcon ALC recently announced the U.S. introduction of its Clareon Toric intraocular lens (IOL) at the upcoming American Academy of Ophthalmology (AAO) 2022 annual meeting in Chicago. With this, the company will complete offering its extensive Clareon portfolio in this region.
Clareon Toric IOL, which is a glistening-free toric intraocular lens, is claimed to provide exceptional clarity and unbeatable stability. Clareon Toric is based on STABLEFORCE Haptics technology, with demonstrated superior rotational and axial stability when compared to TECNIS+ and enVista.4,5+.
Alcon noted that Clareon Toric and Clareon Monofocal consistently deliver a broad refractive landing zone and provide functional intermediate vision while maintaining the expected 20/20 visual acuity at a distance.